10-Q Filing

KYNTRA BIO, INC. CIK: 921299 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0000950170-23-059394`
Period End Date	20230930
Filing Date	20231106
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	fgen-20230930_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 104 Income Statement 72 Cash Flow Statement 94 Stockholders Equity 34 Comprehensive Income 20

Balance Sheet 104 line items

Line Item	Tag	Value	Unit	Period
Accounts Receivable, after Allowance for Credit Loss, Current, Total	`AccountsReceivableNetCurrent`	$31.69M	USD	Point-in-time
Accounts Receivable, after Allowance for Credit Loss, Current, Total	`AccountsReceivableNetCurrent`	$16.30M	USD	Point-in-time
Accounts receivable from related parties	`AccountsReceivableNetCurrentRelatedParties`	$22.92M	USD	Point-in-time
Accounts receivable from related parties	`AccountsReceivableNetCurrentRelatedParties`	$12.09M	USD	Point-in-time
Accrued and other current liabilities to related party	`OtherLiabilitiesCurrentDueToRelatedParties`	$63.89M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$155.70M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$120.91M	USD	Point-in-time
Accrued and other current liabilities to related party	`OtherLiabilitiesCurrentDueToRelatedParties`	$29.16M	USD	Point-in-time
Deferred revenue current to related party	`DueToRelatedPartiesDeferredRevenueCurrent`	$5.48M	USD	Point-in-time
Deferred revenue current to related party	`DueToRelatedPartiesDeferredRevenueCurrent`	$9.26M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$266.31M	USD	Point-in-time
Short-term investments	`ShortTermInvestments`	$130.43M	USD	Point-in-time
Deferred revenue non-current to related party	`DueToRelatedPartiesDeferredRevenueNoncurrent`	$4.67M	USD	Point-in-time
Deferred revenue non-current to related party	`DueToRelatedPartiesDeferredRevenueNoncurrent`	$31.04M	USD	Point-in-time
Accounts receivable, net ($22,916 and $12,088 from related parties)	`AccountsReceivableNetCurrent`	$31.69M	USD	Point-in-time
Accounts receivable, net ($22,916 and $12,088 from related parties)	`AccountsReceivableNetCurrent`	$16.30M	USD	Point-in-time
Inventories	`InventoryNet`	$40.70M	USD	Point-in-time
Due to related parties, noncurrent	`OtherLiabilitiesNoncurrentDueToRelatedParties`	$668.00K	USD	Point-in-time
Inventories	`InventoryNet`	$40.44M	USD	Point-in-time
Due to related parties, noncurrent	`OtherLiabilitiesNoncurrentDueToRelatedParties`	-	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$14.08M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$40.38M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Total current assets	`AssetsCurrent`	$492.83M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	125.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	125.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$364.11M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Restricted time deposits	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.07M	USD	Point-in-time
Restricted time deposits	`RestrictedCashAndCashEquivalentsNoncurrent`	$2.07M	USD	Point-in-time
Long-term investments	`LongTermInvestmentExcludingEquityMethodInvestments`	$4.35M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Long-term investments	`LongTermInvestmentExcludingEquityMethodInvestments`	-	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$14.51M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$20.61M	USD	Point-in-time
Equity method investment in unconsolidated variable interest entity	`EquityMethodInvestments`	$4.53M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	225.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	225.00M	shares	Point-in-time
Equity method investment in unconsolidated variable interest entity	`EquityMethodInvestments`	$5.06M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	98.34M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	94.17M	shares	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$71.25M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$79.89M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	98.34M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$3.95M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.28M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	94.17M	shares	Point-in-time
Total assets	`Assets`	$610.09M	USD	Point-in-time
Total assets	`Assets`	$460.43M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$30.76M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$19.22M	USD	Point-in-time
Accrued and other current liabilities ($29,157 and $63,886 to a related party)	`AccruedLiabilitiesAndOtherLiabilities`	$219.77M	USD	Point-in-time
Accrued and other current liabilities ($29,157 and $63,886 to a related party)	`AccruedLiabilitiesAndOtherLiabilities`	$170.99M	USD	Point-in-time
Deferred revenue ($5,482 and $9,259 to related parties)	`ContractWithCustomerLiabilityCurrent`	$7.33M	USD	Point-in-time
Deferred revenue ($5,482 and $9,259 to related parties)	`ContractWithCustomerLiabilityCurrent`	$12.74M	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$10.29M	USD	Point-in-time
Operating lease liabilities, current	`OperatingLeaseLiabilityCurrent`	$11.88M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$273.56M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$209.41M	USD	Point-in-time
Product development obligations	`AccruedProductDevelopmentCosts`	$16.92M	USD	Point-in-time
Product development obligations	`AccruedProductDevelopmentCosts`	$16.94M	USD	Point-in-time
Deferred revenue, net of current	`ContractWithCustomerLiabilityNoncurrent`	$154.21M	USD	Point-in-time
Deferred revenue, net of current	`ContractWithCustomerLiabilityNoncurrent`	$185.72M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$70.03M	USD	Point-in-time
Operating lease liabilities, non-current	`OperatingLeaseLiabilityNoncurrent`	$79.59M	USD	Point-in-time
Senior secured term loan facilities, non-current	`SecuredLongTermDebt`	$71.67M	USD	Point-in-time
Senior secured term loan facilities, non-current	`SecuredLongTermDebt`	-	USD	Point-in-time
Liability related to sale of future revenues, non-current	`LiabilityRelatedToSaleOfFutureRevenuesNonCurrent`	$49.11M	USD	Point-in-time
Liability related to sale of future revenues, non-current	`LiabilityRelatedToSaleOfFutureRevenuesNonCurrent`	$49.33M	USD	Point-in-time
Other long-term liabilities ($668 and $0 to a related party)	`OtherLiabilitiesNoncurrent`	$6.44M	USD	Point-in-time
Other long-term liabilities ($668 and $0 to a related party)	`OtherLiabilitiesNoncurrent`	$4.25M	USD	Point-in-time
Total liabilities	`Liabilities`	$611.57M	USD	Point-in-time
Total liabilities	`Liabilities`	$575.63M	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and Contingencies (Note 12)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Redeemable non-controlling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	-	USD	Point-in-time
Redeemable non-controlling interests	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$21.48M	USD	Point-in-time
Preferred stock, $0.01 par value; 125,000 shares authorized; no shares issued and outstanding at September 30, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value; 125,000 shares authorized; no shares issued and outstanding at September 30, 2023 and December 31, 2022	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value; 225,000 shares authorized at September 30, 2023 and December 31, 2022; 98,339 and 94,166 shares issued and outstanding at September 30, 2023 and December 31, 2022	`CommonStockValue`	$942.00K	USD	Point-in-time
Common stock, $0.01 par value; 225,000 shares authorized at September 30, 2023 and December 31, 2022; 98,339 and 94,166 shares issued and outstanding at September 30, 2023 and December 31, 2022	`CommonStockValue`	$983.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.63B	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$1.54B	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-6.92M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-5.72M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.56B	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-1.79B	USD	Point-in-time
Total stockholders' deficit attributable to FibroGen	`StockholdersEquity`	$-157.17M	USD	Point-in-time
Total stockholders' deficit attributable to FibroGen	`StockholdersEquity`	$-21.45M	USD	Point-in-time
Nonredeemable non-controlling interests	`NonredeemableNoncontrollingInterest`	$19.97M	USD	Point-in-time
Nonredeemable non-controlling interests	`NonredeemableNoncontrollingInterest`	$20.49M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.48M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-136.68M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$46.27M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$229.11M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-81.79M	USD	Point-in-time
Total deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$123.75M	USD	Point-in-time
Total liabilities, redeemable non-controlling interests and deficit	`LiabilitiesAndStockholdersEquity`	$610.09M	USD	Point-in-time
Total liabilities, redeemable non-controlling interests and deficit	`LiabilitiesAndStockholdersEquity`	$460.43M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$15.73M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$120.61M	USD	3 Qtrs
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$40.13M	USD	1 Quarter
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$106.37M	USD	3 Qtrs
Cost of goods sold	`CostOfRevenue`	$4.24M	USD	1 Quarter
Cost of goods sold	`CostOfRevenue`	$13.44M	USD	3 Qtrs
Cost of goods sold	`CostOfRevenue`	$4.31M	USD	1 Quarter
Cost of goods sold	`CostOfRevenue`	$15.36M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$75.18M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$235.16M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$61.19M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$231.16M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$25.57M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$91.03M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$90.72M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$29.90M	USD	1 Quarter
Restructuring charge	`RestructuringCharges`	-	USD	3 Qtrs
Restructuring charge	`RestructuringCharges`	$12.61M	USD	1 Quarter
Restructuring charge	`RestructuringCharges`	$12.61M	USD	3 Qtrs
Restructuring charge	`RestructuringCharges`	-	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$348.23M	USD	3 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$341.24M	USD	3 Qtrs
Total operating costs and expenses	`CostsAndExpenses`	$103.62M	USD	1 Quarter
Total operating costs and expenses	`CostsAndExpenses`	$109.39M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-227.62M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-234.87M	USD	3 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-93.66M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-63.48M	USD	1 Quarter
Interest expense	`InterestExpense`	$5.02M	USD	1 Quarter
Interest expense	`InterestExpense`	$84.00K	USD	1 Quarter
Interest expense	`InterestExpense`	$321.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$10.46M	USD	3 Qtrs
Interest income and other income (expenses), net	`NonoperatingIncomeExpense`	$7.98M	USD	3 Qtrs
Interest income and other income (expenses), net	`NonoperatingIncomeExpense`	$1.80M	USD	1 Quarter
Interest income and other income (expenses), net	`NonoperatingIncomeExpense`	$4.30M	USD	1 Quarter
Interest income and other income (expenses), net	`NonoperatingIncomeExpense`	$6.67M	USD	3 Qtrs
Total interest and other, net	`InterestIncomeExpenseNonoperatingNet`	$-726.00K	USD	1 Quarter
Total interest and other, net	`InterestIncomeExpenseNonoperatingNet`	$-2.48M	USD	3 Qtrs
Total interest and other, net	`InterestIncomeExpenseNonoperatingNet`	$1.71M	USD	1 Quarter
Total interest and other, net	`InterestIncomeExpenseNonoperatingNet`	$6.35M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-64.21M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-230.10M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-228.52M	USD	3 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-91.94M	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$114.00K	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$-77.00K	USD	3 Qtrs
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$84.00K	USD	1 Quarter
Provision for (benefit from) income taxes	`IncomeTaxExpenseBenefit`	$250.00K	USD	3 Qtrs
Investment income in unconsolidated variable interest entity	`IncomeLossFromEquityMethodInvestments`	$2.02M	USD	3 Qtrs
Investment income in unconsolidated variable interest entity	`IncomeLossFromEquityMethodInvestments`	$677.00K	USD	1 Quarter
Investment income in unconsolidated variable interest entity	`IncomeLossFromEquityMethodInvestments`	$1.29M	USD	3 Qtrs
Investment income in unconsolidated variable interest entity	`IncomeLossFromEquityMethodInvestments`	$407.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-91.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-227.48M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-228.00M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-63.62M	USD	1 Quarter
Net loss per share - basic	`EarningsPerShareBasic`	$-2.35	USD	3 Qtrs
Net loss per share - basic	`EarningsPerShareBasic`	$-2.43	USD	3 Qtrs
Net loss per share - basic	`EarningsPerShareBasic`	$-0.98	USD	1 Quarter
Net loss per share - basic	`EarningsPerShareBasic`	$-0.65	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.65	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	$-2.43	USD	3 Qtrs
Net loss per share - diluted	`EarningsPerShareDiluted`	$-0.98	USD	1 Quarter
Net loss per share - diluted	`EarningsPerShareDiluted`	$-2.35	USD	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	96.90M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	98.25M	shares	1 Quarter
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	93.43M	shares	3 Qtrs
Basic	`WeightedAverageNumberOfSharesOutstandingBasic`	93.77M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	93.77M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	98.25M	shares	1 Quarter
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	96.90M	shares	3 Qtrs
Diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	93.43M	shares	3 Qtrs

Cash Flow Statement 94 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-227.48M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-228.00M	USD	3 Qtrs
Depreciation	`Depreciation`	$7.65M	USD	3 Qtrs
Depreciation	`Depreciation`	$7.50M	USD	3 Qtrs
Amortization of finance lease right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$402.00K	USD	3 Qtrs
Amortization of finance lease right-of-use assets	`FinanceLeaseRightOfUseAssetAmortization`	$411.00K	USD	3 Qtrs
Net accretion of premium and discount on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$-1.84M	USD	3 Qtrs
Net accretion of premium and discount on investments	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$3.65M	USD	3 Qtrs
Investment income in unconsolidated variable interest entity	`InvestmentGainLossInUnconsolidatedVariableInterestEntity`	$1.29M	USD	3 Qtrs
Investment income in unconsolidated variable interest entity	`InvestmentGainLossInUnconsolidatedVariableInterestEntity`	$2.02M	USD	3 Qtrs
Loss (gain) on disposal of property and equipment	`GainLossOnDispositionOfAssets`	$3.00K	USD	3 Qtrs
Loss (gain) on disposal of property and equipment	`GainLossOnDispositionOfAssets`	$-1.00K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$41.47M	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$49.38M	USD	3 Qtrs
Acquired In-process Research and Development Expenses	`AcquiredInProcessResearchAndDevelopmentExpenses`	-	USD	3 Qtrs
Acquired In-process Research and Development Expenses	`AcquiredInProcessResearchAndDevelopmentExpenses`	$24.64M	USD	3 Qtrs
Non-cash interest expense related to sale of future revenues	`NonCashInterestExpenseRelatedToSaleOfFutureRevenues`	-	USD	3 Qtrs
Non-cash interest expense related to sale of future revenues	`NonCashInterestExpenseRelatedToSaleOfFutureRevenues`	$5.64M	USD	3 Qtrs
Dividend received from unconsolidated variable interest entity	`DividendReceivedFromUnconsolidatedVariableInterestEntity`	$2.25M	USD	3 Qtrs
Dividend received from unconsolidated variable interest entity	`DividendReceivedFromUnconsolidatedVariableInterestEntity`	-	USD	3 Qtrs
Impairment of investment	`ImpairmentOfInvestments`	$1.00M	USD	3 Qtrs
Impairment of investment	`ImpairmentOfInvestments`	-	USD	3 Qtrs
Realized loss on sales of available-for-sale securities	`DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment`	$-5.00K	USD	3 Qtrs
Realized loss on sales of available-for-sale securities	`DebtSecuritiesAvailableForSaleRealizedGainLossExcludingOtherThanTemporaryImpairment`	$-271.00K	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$16.28M	USD	3 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-983.00K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$11.15M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$1.52M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-8.27M	USD	3 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$27.39M	USD	3 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-7.76M	USD	3 Qtrs
Operating lease right-of-use assets	`IncreaseDecreaseInOperatingLeaseRightOfUseAssets`	$-8.45M	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-962.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-823.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-5.12M	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-14.06M	USD	3 Qtrs
Accrued and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$-50.25M	USD	3 Qtrs
Accrued and other liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$87.17M	USD	3 Qtrs
Operating lease liabilities, current	`IncreaseDecreaseInOperatingLeaseLiabilitiesCurrent`	$1.67M	USD	3 Qtrs
Operating lease liabilities, current	`IncreaseDecreaseInOperatingLeaseLiabilitiesCurrent`	$715.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-36.93M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$4.51M	USD	3 Qtrs
Accrued interest for finance lease liabilities	`IncreaseDecreaseInAccruedInterestForFinanceLeaseLiabilities`	$-68.00K	USD	3 Qtrs
Accrued interest for finance lease liabilities	`IncreaseDecreaseInAccruedInterestForFinanceLeaseLiabilities`	$-22.00K	USD	3 Qtrs
Operating lease liabilities, non-current	`IncreaseDecreaseInOperatingLeaseLiabilitiesNonCurrent`	$-9.45M	USD	3 Qtrs
Operating lease liabilities, non-current	`IncreaseDecreaseInOperatingLeaseLiabilitiesNonCurrent`	$-7.41M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-10.26M	USD	3 Qtrs
Other long-term liabilities	`IncreaseDecreaseInOtherNoncurrentLiabilities`	$-1.53M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-296.70M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-93.42M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$3.41M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$2.27M	USD	3 Qtrs
Payment made for acquired in-process research and development asset	`PaymentsToAcquireInProcessResearchAndDevelopment`	$35.00M	USD	3 Qtrs
Payment made for acquired in-process research and development asset	`PaymentsToAcquireInProcessResearchAndDevelopment`	-	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$8.00K	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	3 Qtrs
Purchases of available-for-sale securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$97.30M	USD	3 Qtrs
Purchases of available-for-sale securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$157.21M	USD	3 Qtrs
Cash acquired from consolidation of Fortis	`CashAcquiredFromAcquisition`	-	USD	3 Qtrs
Cash acquired from consolidation of Fortis	`CashAcquiredFromAcquisition`	$656.00K	USD	3 Qtrs
Proceeds from sales of available-for-sale securities	`ProceedsFromSalesOfAvailableForSaleSecurities`	$1.73M	USD	3 Qtrs
Proceeds from sales of available-for-sale securities	`ProceedsFromSalesOfAvailableForSaleSecurities`	$7.38M	USD	3 Qtrs
Proceeds from maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$300.51M	USD	3 Qtrs
Proceeds from maturities of investments	`ProceedsFromSaleMaturityAndCollectionsOfInvestments`	$216.34M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$88.02M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$143.41M	USD	3 Qtrs
Proceeds from senior secured term loan facilities, net of issuance costs	`ProceedsFromIssuanceOfSecuredDebt`	$74.08M	USD	3 Qtrs
Proceeds from senior secured term loan facilities, net of issuance costs	`ProceedsFromIssuanceOfSecuredDebt`	-	USD	3 Qtrs
Cash paid for transaction costs for senior secured term loan facilities	`RepaymentsOfSecuredDebt`	-	USD	3 Qtrs
Cash paid for transaction costs for senior secured term loan facilities	`RepaymentsOfSecuredDebt`	$2.75M	USD	3 Qtrs
Repayments of finance lease liabilities	`RepaymentsOfFinanceLeaseLiabilities`	$23.00K	USD	3 Qtrs
Repayments of finance lease liabilities	`RepaymentsOfFinanceLeaseLiabilities`	$128.00K	USD	3 Qtrs
Repayments of lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$302.00K	USD	3 Qtrs
Repayments of lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$302.00K	USD	3 Qtrs
Cash paid for payroll taxes on restricted stock unit releases	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	-	USD	3 Qtrs
Cash paid for payroll taxes on restricted stock unit releases	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$4.56M	USD	3 Qtrs
Proceeds from issuance of common stock under ATM Program, net of commissions	`ProceedsFromIssuanceInitialPublicOffering`	$48.41M	USD	3 Qtrs
Proceeds from issuance of common stock under ATM Program, net of commissions	`ProceedsFromIssuanceInitialPublicOffering`	-	USD	3 Qtrs
Proceeds from issuance of common stock under employee stock plans	`ProceedsFromIssuanceOfCommonStock`	$3.69M	USD	3 Qtrs
Proceeds from issuance of common stock under employee stock plans	`ProceedsFromIssuanceOfCommonStock`	$2.99M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$123.00M	USD	3 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-1.90M	USD	3 Qtrs
Effect of exchange rate change on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-7.97M	USD	3 Qtrs
Effect of exchange rate change on cash and cash equivalents	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$-4.50M	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-15.26M	USD	3 Qtrs
Net decrease in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-34.79M	USD	3 Qtrs
Total cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$120.91M	USD	Point-in-time
Total cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$155.70M	USD	Point-in-time
Total cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$155.96M	USD	Point-in-time
Total cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$171.22M	USD	Point-in-time
Total cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$120.91M	USD	Point-in-time
Total cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$155.70M	USD	Point-in-time
Total cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$155.96M	USD	Point-in-time
Total cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$171.22M	USD	Point-in-time

Stockholders Equity 34 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.48M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-136.68M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$46.27M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$229.11M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-81.79M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$123.75M	USD	Point-in-time
Net loss	`NetIncomeLoss`	$-91.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-227.48M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-228.00M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-63.62M	USD	1 Quarter
Consolidation of Fortis (Note 3)	`StockIssuedDuringPeriodSharesAcquisitions`	520,000.00	shares	3 Qtrs
Change in unrealized gain or loss on investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$360.00K	USD	1 Quarter
Change in unrealized gain or loss on investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$-3.15M	USD	3 Qtrs
Change in unrealized gain or loss on investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$20.00K	USD	1 Quarter
Change in unrealized gain or loss on investments	`OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax`	$2.42M	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-28.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.03M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-436.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-3.62M	USD	3 Qtrs
Issuance of common stock under ATM Program	`StockIssuedDuringPeriodValueNewIssues`	$48.41M	USD	3 Qtrs
Shares issued from stock plans, net of payroll taxes paid	`AdjustmentsToAdditionalPaidInCapitalSharesIssuedFromStockPlansNetOfPayrollTaxesPaid`	$3.60M	USD	3 Qtrs
Shares issued from stock plans, net of payroll taxes paid	`AdjustmentsToAdditionalPaidInCapitalSharesIssuedFromStockPlansNetOfPayrollTaxesPaid`	$-1.57M	USD	3 Qtrs
Shares issued from stock plans, net of payroll taxes paid	`AdjustmentsToAdditionalPaidInCapitalSharesIssuedFromStockPlansNetOfPayrollTaxesPaid`	$-993.00K	USD	1 Quarter
Shares issued from stock plans, net of payroll taxes paid	`AdjustmentsToAdditionalPaidInCapitalSharesIssuedFromStockPlansNetOfPayrollTaxesPaid`	$-83.00K	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$49.40M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$41.47M	USD	3 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$15.59M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$9.48M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.48M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-136.68M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$46.27M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$229.11M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-81.79M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$123.75M	USD	Point-in-time

Comprehensive Income 20 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-91.65M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-227.48M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-228.00M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-63.62M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-28.00K	USD	3 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-1.03M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-436.00K	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-3.62M	USD	3 Qtrs
Unrealized gain (loss) on investments, net of tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-3.15M	USD	3 Qtrs
Unrealized gain (loss) on investments, net of tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$20.00K	USD	1 Quarter
Unrealized gain (loss) on investments, net of tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$2.42M	USD	3 Qtrs
Unrealized gain (loss) on investments, net of tax effect	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$360.00K	USD	1 Quarter
Other comprehensive gain (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTax`	$-1.20M	USD	3 Qtrs
Other comprehensive gain (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTax`	$-3.18M	USD	3 Qtrs
Other comprehensive gain (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTax`	$-416.00K	USD	1 Quarter
Other comprehensive gain (loss), net of taxes	`OtherComprehensiveIncomeLossNetOfTax`	$-673.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-64.29M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-229.20M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-230.66M	USD	3 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-92.07M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.